The Australian and Chinese governments will commit $9 million each to a new Australia-China Science and Research Fund from 2011-12.
Former vice-chancellor of the Australian National University, Professor Ian Chubb AC, has been appointed Chief Scientist.
Scientists and the general public gather at the Rally for Research in Melbourne to show support for health and medical research and to protest proposed cuts to the NHMRC budget.
Sigma Pharmaceuticals (ASX:SIP) end of year numbers were well received by the market today with shares rising 4.5c to close at 46c, on markedly improved results compared to prior year.
The federal government will overhaul the clinical trials process in Australia after accepting recommendations of the long awaited Clinical Trials Action Group report.
Australia's Chief Scientist, Professor Penny Sackett, has stunned the scientific community with her sudden resignation today.
Nominations are now open for the prestigious Prime Minister's Prizes for Science.
Acquisitions are commonplace in the IT industry. ARN investigates what makes the difference between a successful acquisition or merger, and where things can (and do) go wrong.
bioMD is looking to acquire Allied Medical, which also owns Coridon, led by Ian Frazer, to produce a new diversified healthcare company.
Keeping a life science lab running smoothly and safely has become an increasingly complex and demanding task.
US technology company, Danaher, is to acquire Beckman Coulter in a deal worth US$6.8 billion.
Dr Uta Wille bridges the gap between chemistry and biology and is bringing her unique insight to bear on the role played by free radicals in damaging DNA.
The Excellence in Research for Australia 2010 report shows that Australian researchers produce world class output in immunology, quantum physics and history, but fall behind in other areas.
Eight out of the 34 universities surveyed in the Excellence in Research Australia report produce life science research that is well above the world standard.
The Australian Academy of Science will hold a public lecture series that will serve as a tribute to the life and achievements of the late Frank Fenner.